Skip to main content
Premium Trial:

Request an Annual Quote

Centogene: New CentoXome

Centogene has launched New CentoXome, a whole-exome sequencing test that the company claims increases diagnostic yield by up to 20 percent compared to conventional WES assays. The test offers enhanced coverage of the exome, mitochondrial genome, and medically relevant genes and variants. It also has improved clinical reporting based on bioinformatics, artificial intelligence, and analysis of Centogene's database by medical experts, according to the firm.